- Home
- About Us
- Service
- Application
- Technology
- Contact Us
News and Events
ASCO 2025 Highlights: HaploX Presents 8 Research Studies, Revealing New Breakthroughs in MRD, Early Screening & Diagnosis, and Tumor Biomarkers
2025-06-05
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting will be held from May 30 to June 3 (Eastern Time, ET) in Chicago, USA. As the world's largest, most academically rigorous, and authoritative conference in clinical oncology, the ASCO Annual Meeting brings together physicians, professionals, patient advocates, industry representatives, and major media from across the global oncology field to focus on cutting-edge international research discoveries and clinical trial results.
HaploX, in collaboration with leading clinical experts, has successfully had 8 research studies selected for presentation at this year's ASCO Annual Meeting. These studies cover multiple cancer types, including bladder cancer, lung cancer, liver cancer, colorectal cancer, and kidney cancer. The research focuses on key areas such as molecular residual disease (MRD), early screening and diagnosis, and the exploration of biomarkers.
Four of these studies will be presented as Poster Presentations. We look forward to engaging with experts attending the conference!
During the conference, we will provide detailed coverage of these research findings. Stay tuned!
Access HaploX's Selected Research at ASCO 2025：
https://meetings.asco.org/abstracts-presentations/search?query=&q=haplox&pageNumber=1&filters=%7B%22meetingYear%22:%5B%7B%22key%22:%222025%22%7D%5D%7D
Address
Units 610, 6/F, Building 16W, Phase 3, HongKong Science Park, New Territories, HongKong
Phone
+852 69410851
customer_service@haplox.net
© Copyright Job Portal 2025.
